The Dermatology Digest

SEPTEMBER 9, 2024

Obagi Introduces Two New Elastiderm Products Obagi Medical is launching Elastiderm Lift Up & Sculpt Facial Moisturizer and Elastiderm Advanced Filler Concentrate.

Portfolios 36

Portfolios Dermatology Injections Marketing 36

AAAMS

FEBRUARY 22, 2023

Unfortunately, a steep road awaits nurses who exit the medical field entirely. If you’re still passionate and ambitious when it comes to working in the medical field, consider pivoting to a different sector of health care: aesthetic medicine! Practitioners are free and encouraged to exercise their best medical judgment.

Work-Life Balance 52

Work-Life Balance Training Office Marketing 52

NIMA Institute

JUNE 30, 2023

Nima, a trusted name in medical esthetician training, offers an exceptional program to help you become a skilled and sought-after makeup artist. Business and Marketing Skills: Becoming a successful makeup artist requires more than just technical expertise. Nima’s commitment to your success doesn’t end with graduation.

Makeup 52

Makeup Social Media Training Portfolios 52

The Dermatology Digest

MARCH 27, 2024

Alexis (Lexi) Stern is Merz Aesthetics’ new Chief Marketing Officer. Stern will join the global leadership team and will be responsible for leading the portfolio and brand strategies. Stern served as Senior Vice President of Global Marketing at Covergirl, Coty Inc.’s Most recently, Ms.

Office 36

Office Portfolios Branding Marketing 36

The Dermatology Digest

APRIL 1, 2024

There remains a significant need for new, innovative treatment for vitiligo and other immune-mediated dermatologic conditions, and we look forward to working together with the CMS team to bringing these products to market in China.” The transaction is effective immediately upon the execution of the Collaboration and License Agreement.

Portfolios 36

Portfolios Injections Innovations Sales 36

Aesthetics Advisor

SEPTEMBER 15, 2023

However, medications that are already authorized are just a small percentage of what's been studied. Many researchers are still trying to find and develop other medications that can treat or prevent COVID-19. The product is authorized as a medical device targeting COVID-19 in India, Israel, Bahrain, Indonesia and Thailand.

Hospital 69

Hospital Clinic Marketing Medical 69

The Dermatology Digest

DECEMBER 21, 2023

“We are increasingly optimistic about the near-term potential that the next-generation technology in the Evolysse and Estyme fillers lines will offer customers in the fast-growing facial HA market. and Europe,” adds Jean-Paul Gérardin, CEO of Symatese, a privately held French company specializing in Class I to III medical devices. “We

Marketing 36

Marketing Sales Branding Portfolios 36

The Dermatology Digest

DECEMBER 21, 2023

“We are increasingly optimistic about the near-term potential that the next-generation technology in the Evolysse and Estyme fillers lines will offer customers in the fast-growing facial HA market. and Europe,” adds Jean-Paul Gérardin, CEO of Symatese, a privately held French company specializing in Class I to III medical devices. “We

Marketing 36

Marketing Sales Branding Portfolios 36

Spa Executive

JUNE 19, 2024

Managing an extensive portfolio of more than 120 hotels, including 26 major brands and 19 boutique properties, Remington has positioned itself as a leader in the hospitality industry. Remington also places a strong emphasis on innovation and adapting to market trends. Can you please talk about your role and what it entails?

Hospital 52

Hospital Technology Sustainability Management 52

The Dermatology Digest

OCTOBER 1, 2024

market for all of BOTOX’s currently approved and future therapeutic indications under a single approval.” Wang, MD, MBE, MBA, Medical Research Director at Laser & Skin Surgery Center of New York, and Medical Director at Laser & Skin Surgery Center of Pennsylvania, in a news release.

Hydration 36

Hydration Portfolios Office Surgery 36

The Eco Well Blog

MAY 8, 2023

Her area of clinical expertise is in complex medical dermatology, skin cancer, and acne. She has published numerous articles in peer-reviewed medical journals on the science of the skin barrier, electron microscopy, and congenital skin diseases. Carl presented at the Sunscreen E-Summit on behalf of DSM. She holds a B.S.

Legal 52

Legal Technology Sun Protection Branding 52

The Dermatology Digest

NOVEMBER 4, 2024

The EU Medical Device Regulation (MDR) certification gave its nod to four injectable hyaluronic acid (HA) gel fillers from Evolus under the brand name Estyme, The CE Mark certification, through the new MDR process, represents more stringent requirements, designed to ensure the safety, efficacy, and quality of medical devices sold in Europe.

Injections 68

Injections Medical Portfolios Branding 68

The Dermatology Digest

FEBRUARY 13, 2025

This milestone represents an exciting new chapter in our long-term strategy to expand our portfolio and transition from a single-product company to a multi-product innovator, strengthening our leadership in performance beauty, says David Moatazedi, President and Chief Executive Officer of Evolus, in a news release. market in Q2 2025.

Injections 73

Injections Portfolios Safety Innovations 73

The Dermatology Digest

MARCH 27, 2025

We are thrilled to announce this agreement with Kaken, a dermatology leader with significant reach and expertise in the Japanese market, says Martin Babler, President and Chief Executive Officer of Alumis, in a news release. ESK-001 will be an important addition to the Kaken portfolio of novel therapeutics for dermatology conditions.

Pharmaceutical 36

Pharmaceutical Portfolios Clinic Safety 36